Palbociclib for treating high-risk early breast cancer after neoadjuvant chemotherapy [ID3846]

  • Awaiting development
  • GID-TA10723
  • Expected publication date: TBC

Status:
Awaiting development
Decision:
None selected
Process:
TA
ID number:
3846

For further information on our processes and methods, please see our CHTE processes and methods manual